top of page

Updates

News, milestones, and insights from NeutroGen Therapeutics. Follow our journey as we develop innovative neutrophil-based therapies to address critical unmet medical needs in oncology and infectious diseases.

Press Contact

ADDRESS

NeutroGen Therapeutics GmbH
c/o Bayer AG, Co.Labs (S107/11)
Müllerstraße 178
DE-13353 Berlin

CONTACT Person

Holger Münchmeyer
contact@neutrogen-therapeutics.com

bottom of page